Family Outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis

JFM Gleeson; SM Cotton; M Alvarez-Jimenez; D Wade; K Crisp; B Newman; D Spiliotacopoulos; PD McGorry Md

Journal article

Family Outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis

JFM Gleeson, SM Cotton, M Alvarez-Jimenez, D Wade, K Crisp, B Newman, D Spiliotacopoulos, PD McGorry Md

Journal of Clinical Psychiatry | Published : 2010

DOI: 10.4088/JCP.08m04672yel

Abstract

Objective: We have previously reported that our combined individual and family cognitive-behavioral therapy (CBT) relapse prevention therapy (RPT) was effective in reducing relapse rates compared to treatment as usual (TAU) within a specialist program for young, first-episode psychosis patients who had reached remission on positive symptoms. Here, we report the outcomes for family participants of DSM-IV-diagnosed first-episode psychosis patients recruited between November 2003 and May 2005 over a 2.5-year follow-up period. The primary hypothesis was that, compared to family members receiving TAU, family participants who received RPT would have significantly improved appraisals of stressors r..

View full abstract

University of Melbourne Researchers

Susan Cotton Author

Mario Alvarez-Jimenez Author

Daniela Cagliarini Author

Patrick McGorry Author

Related Projects (1)

EMERGING SEVERE MENTAL ILLNESS IN YOUNG PEOPLE

Mental disorders, such as psychotic and severe mood disorders, are the largest cause of disability in Australia. However, there is still lit..

Grants

Awarded by National Health and Medical Research Council of Australia

Funding Acknowledgements

This study was funded by an unrestricted grant from Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium. In addition, the study was supported by the Colonial Foundation and a Program Grant from the National Health and Medical Research Council of Australia, grant ID 350241. The salary for Dr Alvarez-Jimenez was funded by Marques de Valdecilla Public Foundation-Research Institute (FMV-IFIMAV).